The Origins of SARS-CoV-2 · source record · report

Independent assessment of the origins of SARS-CoV-2 by the Scientific Advisory Group for the Origins of Novel Pathogens

World Health Organization · 2025

AI-verified citationSRC-SAGO-2025

identifier / locator: 78-page report, June 2025; the served file is WHO's post-publication corrected version
url: https://www.who.int/publications/m/item/independent-assessment-of-the-origins-of-sars-cov-2-from-the-scientific-advisory-group-for-the-origins-of-novel-pathogens
verification note: Full PDF fetched from WHO and verified page by page 2026-08-26. Two statements attributed to this report in the casework digest are NOT in it and were rejected: the word "surprising" appears nowhere in the document, and it contains no sentence contrasting the two-lineage pattern with a single introduction expected from a laboratory leak.
reliability notes: The best current international scientific synthesis and simultaneously an indictment of the data environment: it states it had no access to original raw data from any source.
Requested information was not provided by three governments — China, Germany, and the United States — not by China alone.
Its summaries of the intelligence assessments are accurate but not independent of them; the underlying reports are cited directly here.
The file WHO now serves is a corrected version, so page locators can differ from the June 2025 original; the version read is recorded.

Evidence drawn from this source

Supports· moderateCOV-E007

WHO's assessment of the co-location evidence, and of the testing that was not done

what the source states: "Currently, the most compelling evidence of a possible spillover from animals to humans comes from the independent metagenomic data analysis, which confirmed the presence of mitochondrial DNA of animals known to be susceptible in stalls at the HSM, and SARS-CoV-2 positive environmental swabs from the same stalls. The data confirms that these animals were present before the market was closed on 1 January 2020 and may have been a source for human infection." On the limits of the animal testing: "Despite some testing of the environment and animals sampled from the HSM, there was a limited number of susceptible species included in this testing, thus limiting the ability to make definitive conclusions. It is likely that many animals had already been removed due to public health measures imposed on 1 January 2020, when the market was shut down and disinfected; therefore, they were not traced for sampling."
what we infer: An independent expert body reaching the same two-sided reading this case reaches: the co-location is the strongest market evidence available and it establishes possibility rather than fact. The second passage is the authoritative statement of why the negative animal results are weak.
limitations: A synthesis of accessible evidence by a body that states it had no access to original raw data from any source.
Not independent of the underlying papers it reviews.

World Health Organization (2025)AI-verified citationCOV-C006 COV-C007

Qualifies· moderateCOV-E008

WHO's scepticism about China's reported animal-testing results

what the source states: "It has been reported to SAGO and WHO that no stored samples from animals in China taken before the first identified human cases of COVID-19 (January 2020) were SARS-CoV-2-positive. This has not been independently verified by SAGO. However, it seems unlikely that there have been no animal SARS-CoV-2 reverse zoonotic infections in China since the onset of the COVID-19 pandemic (aside from Syrian hamsters in Hong Kong Special Administrative Region), considering the many susceptible species present there, the reverse zoonoses events reported in various susceptible species around the world, and the possibility of exposure to potentially infected animals at source farms and the HSM."
what we infer: Quoted at length because it is widely misreported, including in this case's own research brief, as WHO calling the missing intermediate host "surprising." It says something different and narrower: that the reported absence of ANY human-to-animal infections in China since the pandemic began is implausible. That is scepticism about the completeness of China's post-pandemic animal testing, which cuts against the reliability of the same negative results the zoonotic case is often criticized with.
limitations: An expert body's expression of doubt about another party's reported results, not an independent test of them.

World Health Organization (2025)AI-verified citationCOV-C007

Qualifies· moderateCOV-E012

WHO reports the two-introduction finding without drawing the lab-leak contrast

what the source states: "Based on phylogeny and empirical mutation frequencies, initial and updated analyses considering all currently available sequence data, Pekar et al. proposed that a single introduction of SARS-CoV-2 into the human population is 'highly unlikely'. These findings suggest two slightly different but distinct genetic virus variants: lineage A and lineage B." And, separately: "Analysis of available genomes provides evidence of two separate introductions of SARS-CoV-2 virus lineages … These findings and evolutionary analyses suggest that these introductions occurred after November 2019."
what we infer: Recorded to correct a misattribution this case had to catch. The WHO report is widely cited — including in this case's research brief — as contrasting the two-lineage pattern with the single introduction a laboratory leak would produce. It contains no such sentence. It reports the finding and attributes the "highly unlikely" judgment to the original authors. The inference that two introductions disfavor a single laboratory index infection is a reasonable one, but it is this case's inference, not WHO's, and it is recorded here as such.
limitations: A secondary characterization of the underlying analysis, not an independent evaluation of it.

World Health Organization (2025)AI-verified citationCOV-C010

Supports· strongCOV-E014

WHO: genomic features explained by natural evolution — and not refuted as man-made either

what the source states: "evidence around the evolution of the virus suggests that these features likely developed through natural evolution in susceptible animals and humans due to a propensity for recombination and accumulation of mutations associated with coronaviruses … Furin cleavage sites occur in other human coronaviruses and had been previously identified in nature, for example in animal-associated merbecoviruses. This suggests that it could also be acquired in sarbecoviruses through natural recombination events … Based on our knowledge on coronavirus evolution and biology, this and other features of SARS-CoV-2 are readily explained by natural evolution and provide no support to theories of a man-made origin. However, the latter is also not refuted by biological data."
what we infer: The final sentence is the one that must never be dropped, and it is absent from most citation of this passage including this case's own research brief. WHO says the genomic features give no support to a man-made origin and, immediately, that biological data does not refute one. That is the precise epistemic position: the genome is not evidence for engineering, and it cannot exclude it either.
limitations: An expert synthesis rather than new analysis; it reviews published work rather than testing it.

World Health Organization (2025)AI-verified citationCOV-C011 COV-C012

Supports· strongCOV-E021

WHO's conclusion, and its statement that the laboratory hypothesis could not be assessed

what the source states: "The weight of available evidence reviewed by SAGO suggests zoonotic spillover of SARS-CoV-2 into the human population, either directly from bats or through an intermediate host. However, SAGO cannot conclude with certainty where and when this occurred, nor if the HSM was indeed the first instance of spillover into the human population, or the site of further spillover and amplification." And: "Information and evidence is also lacking to assess the possibility of a laboratory origin - either the evidence is not available or has not been provided to the scientific community. As a result, SAGO has been unable to adequately assess this route for human infection and therefore is not in a position to rule this out as a possibility." On its own access: "It is important to note that SAGO did not have access to original raw data from any source in preparing this report."
what we infer: The two halves must always travel together. Note also the qualification "reviewed by SAGO," which ellipsis usually removes and which is the whole point: the weight of the evidence that could be seen. The report's own statement that it had no access to raw data from any source is the most important sentence in it for calibrating everything else.
limitations: The file WHO now serves is a post-publication corrected version, so page locators can differ from the June 2025 original; the version read is recorded in the source.
Not independent of the papers and assessments it reviews.

World Health Organization (2025)AI-verified citationCOV-C015 COV-C001

Qualifies· moderateCOV-E022

Three governments, not one, withheld requested information

what the source states: "SAGO and WHO have requested further information from Member States, - including the Governments of China, Germany and the United States of America. … However, at the time of writing, all of the required information had not been provided to WHO." The three categories named are more than 500 early sequences; detailed information on the sources, locations, sampling and testing of animals sold at the market and other Wuhan markets including upstream farming or illegal trade; and information on research and field activities in Wuhan laboratories, including staff health records and biosafety information.
what we infer: Recorded because the standard framing — that China alone withheld — appears in this case's own research brief and is incomplete. Germany and the United States were also asked and did not fully comply. The three named categories are effectively WHO's own research agenda, and they map directly onto this case's decisive tests.
limitations: A statement of what was requested and not received; it does not establish why, or what the withheld material contains.

World Health Organization (2025)AI-verified citationCOV-C015